A Systematic Screen for Dominant Second-Site Modifiers of Merlin/NF2 Phenotypes Reveals an Interaction With blistered/DSRF and scribbler

Corresponding author: Richard G. Fehon, B333 LSRC, Research Dr., Duke University, Durham, NC 27708-1000., rfehon{at}duke.edu (E-mail)

Communicating editor: K. ANDERSON

Merlin, the Drosophila homologue of the human tumor suppressor gene Neurofibromatosis 2 (NF2), is required for the regulation of cell proliferation and differentiation. To better understand the cellular functions of the NF2 gene product, Merlin, recent work has concentrated on identifying proteins with which it interacts either physically or functionally. In this article, we describe genetic screens designed to isolate second-site modifiers of Merlin phenotypes from which we have identified five multiallelic complementation groups that modify both loss-of-function and dominant-negative Merlin phenotypes. Three of these groups, Group IIa/scribbler (also known as brakeless), Group IIc/blistered, and Group IId/net, are known genes, while two appear to be novel. In addition, two genes, Group IIa/scribbler and Group IIc/blistered, alter Merlin subcellular localization in epithelial and neuronal tissues, suggesting that they regulate Merlin trafficking or function. Furthermore, we show that mutations in scribbler and blistered display second-site noncomplementation with one another. These results suggest that Merlin, blistered, and scribbler function together in a common pathway to regulate Drosophila wing epithelial development.

This article has been cited by other articles:

				M. Curto, B. K. Cole, D. Lallemand, C.-H. Liu, and A. I. McClatchey Contact-dependent inhibition of EGFR signaling by Nf2/Merlin J. Cell Biol., June 21, 2007; 177(5): 893 - 903. [Abstract] [Full Text] [PDF]

				S. C. Hughes and R. G. Fehon Phosphorylation and activity of the tumor suppressor Merlin and the ERM protein Moesin are coordinately regulated by the Slik kinase J. Cell Biol., October 23, 2006; 175(2): 305 - 313. [Abstract] [Full Text] [PDF]

				R. S. Hawley and W. D. Gilliland Sometimes the Result Is Not the Answer: The Truths and the Lies That Come From Using the Complementation Test Genetics, September 1, 2006; 174(1): 5 - 15. [Abstract] [Full Text] [PDF]

				A. I. McClatchey and M. Giovannini Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin Genes & Dev., October 1, 2005; 19(19): 2265 - 2277. [Abstract] [Full Text] [PDF]

				H. Oster, A. Yasui, G. T.J. van der Horst, and U. Albrecht Disruption of mCry2 restores circadian rhythmicity in mPer2 mutant mice Genes & Dev., October 15, 2002; 16(20): 2633 - 2638. [Abstract] [Full Text] [PDF]

				M. Kressel and B. Schmucker Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15 Hum. Mol. Genet., September 15, 2002; 11(19): 2269 - 2278. [Abstract] [Full Text] [PDF]